Stocktoria

OneMedNet Corp ONMD

Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-05-07

OneMedNet Corp statistics & valuation

P / S26.4×
Net margin-206.1%
FCF margin-553.1%
Net cash$365,000
Enterprise value USD$35.6M
Earnings yield EBIT/EV-27.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-540.40% -3308.50% -1575.30% -206.10% 2022202320242025
Gross margin (%)
-31.30% -12.60% -43.70% -37.00% 2022202320242025
Operating margin (%)
-991.20% -671.20% -1493.80% -711.30% 2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
4.6M 23.6M 28.1M 51.8M 2022202320242025
Net debt ($)
$418000 $2.1M -$365000 2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-20.50% -7280.20% -271.80% -130.20% 2022202320242025
Free cash flow margin (%)
7563.00% -473.60% -1089.10% -553.10% 2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
$0.03 -$4.65 -$0.36 -$0.06 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin-37.0%-43.7%-12.6%-31.3%
Operating margin-711.3%-1493.8%-671.2%-991.2%
Net margin-206.1%-1575.3%-3308.5%-540.4%
FCF margin-553.1%-1089.1%-473.6%7563.0%
Return on assets-130.2%-271.8%-7280.2%-20.5%
Return on equity94.5%63.5%251.3%23.6%
Debt / equity-0.07×-0.15×-0.03×
Current ratio0.430.190.032.58

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.